Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose is to evaluate the activity and feasibility of a two drug regimen which is partly orally and partly intravenous in advanced pleural mesothelioma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rigshospitalet, Denmark
• Treatments: Carboplatin; Vinblastine; Vinorelbine

Criteria

Inclusion Criteria:

• Histologically verified malignant pleural Mesothelioma

• Age above 18 years

• Performance status 0-2

Exclusion Criteria:

• No previous chemotherapy

• Normal renal, liver and bone marrow function